Endocrinology · Lancaster, CA
NPI
1376542811
Since 2005
Specialty
Endocrinology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1331 W Avenue J, Suite 206
Lancaster, CA, 93534
Phone (661) 949-8882
Groups this clinician bills Medicare through
Medicare paid, 2024
$325K
3,947 services
Medicare patients, 2024
819
Average age 71
Drug cost, 2024
$3.9M
9,040 prescriptions
Company payments, 2025
$5,187
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ashiq V Patel was code 99214 (office e&m - established), 1,471 times for 540 patients. In total Ashiq V Patel billed 3,947 services in 10 codes, and Medicare paid $325K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,471 | 540 | $96.91 | $143K |
| 99213 Office E&M - Established | Office | 984 | 465 | $65.02 | $64K |
| 99232 Hospital E&M - Subsequent | Facility | 814 | 147 | $58.94 | $48K |
| 99233 Hospital E&M - Subsequent | Facility | 332 | 66 | $88.80 | $29K |
| 99223 Hospital E&M - Initial | Facility | 144 | 120 | $129.58 | $19K |
| 99215 Office E&M - Established | Office | 50 | 43 | $133.92 | $6,696 |
| 99204 Office E&M - New | Office | 50 | 50 | $118.86 | $5,943 |
| 99203 Office E&M - New | Office | 46 | 46 | $80.48 | $3,702 |
| 99222 Hospital E&M - Initial | Facility | 40 | 39 | $97.68 | $3,907 |
| 99205 Office E&M - New | Office | 16 | 16 | $160.27 | $2,564 |
By year: 2022 $454K for 5,257 services; 2023 $361K for 4,054 services; 2024 $325K for 3,947 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ashiq V Patel prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,725 prescriptions and refills. In total Ashiq V Patel wrote 9,040 Medicare prescriptions that cost $3.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,725 | 3,204 | 353 | $18K |
| Jardiance Empagliflozin | 482 | 673 | 106 | $369K |
| Liothyronine Sodium Generic | 396 | 718 | 95 | $18K |
| Ozempic Semaglutide | 395 | 477 | 56 | $436K |
| Rosuvastatin Calcium Generic | 318 | 748 | 83 | $5,230 |
| Atorvastatin Calcium Generic | 236 | 493 | 76 | $1,635 |
| Farxiga Dapagliflozin Propanediol | 233 | 326 | 45 | $175K |
| Metformin Hcl Generic | 216 | 386 | 62 | $1,233 |
| Trulicity Dulaglutide | 213 | 257 | 40 | $241K |
| Synthroid Levothyroxine Sodium | 180 | 422 | 48 | $15K |
| Np Thyroid Thyroid,pork | 179 | 329 | 47 | $17K |
| Armour Thyroid Thyroid,pork | 132 | 223 | 28 | $12K |
| Humulin 70/30 Kwikpen Insulin Nph Hum/Reg Insulin Hm | 122 | 192 | 28 | $17K |
| Methimazole Generic | 122 | 177 | 23 | $988 |
| Simvastatin Generic | 121 | 231 | 27 | $628 |
Brand drugs: 3,671 claims; generic drugs: 4,523 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ashiq V Patel $5,187 ($5,187 in general payments such as food, travel and fees) from 24 companies. The largest payer was Amgen Inc. with $825.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 38 | $825 |
| Xeris Pharmaceuticals, Inc. | 41 | $799 |
| Radius Health, Inc. | 19 | $478 |
| Medtronic, Inc. MDT | 9 | $320 |
| Abbott Laboratories ABT | 30 | $298 |
| IBSA Pharma Inc. | 13 | $289 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $277 |
| Corcept Therapeutics CORT | 15 | $272 |
| CeQur Corporation | 1 | $221 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 8 | $211 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.